Advertisement
Advertisement
ORGO
Organogenesis Holdings Inc. Class A Common Stock
2.55
USDSponsored
+0.16
+6.69%
Jul 27, 15:56 UTC -4
Closed
After-Market
2.50
-0.05
-1.96%
ORGO Earnings Reports
Positive Surprise Ratio
ORGO beat 20 of 29 last estimates.
69%
Next Report
Date of Next Report
Aug 06, 2026
Estimate for Q2 26 (Revenue/ EPS)
$55.34M
/-$0.35
Implied change from Q1 26 (Revenue/ EPS)
+48.64%
/-14.63%
Implied change from Q2 25 (Revenue/ EPS)
-45.22%
/+250.00%
Organogenesis Holdings Inc. Class A Common Stock earnings per share and revenue
On May 07, 2026, ORGO reported earnings of -0.41 USD per share (EPS) for Q1 26, missing the estimate of -0.31 USD, resulting in a -29.66% surprise. Revenue reached 37.23 million, compared to an expected 44.17 million, with a -15.71% difference. The market reacted with a -6.32% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 4 analysts forecast an EPS of -0.35 USD, with revenue projected to reach 55.34 million USD, implying an decrease of -14.63% EPS, and increase of 48.64% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Champions Oncology, Inc.
Report Date
Jul 27, 2026 For Q4 26
Estimate
-$0.05
Actual
-$0.05
Surprise
+1.96%
Summit Therapeutics Inc. Common Stock
Report Date
Jul 23, 2026 For Q2 26
Estimate
-$0.28
Actual
-$0.28
Surprise
+1.72%
FAQ
What were Organogenesis Holdings Inc. Class A Common Stock's earnings and revenue for the latest quarter Q1 2026?
For Q1 2026, Organogenesis Holdings Inc. Class A Common Stock reported EPS of -$0.41, missing estimates by -29.66%, and revenue of $37.23M, -15.71% below expectations.
How did the market react to Organogenesis Holdings Inc. Class A Common Stock's Q1 2026 earnings?
The stock price moved down -6.32%, changed from $2.53 before the earnings release to $2.37 the day after.
When is Organogenesis Holdings Inc. Class A Common Stock expected to report next?
The next earning report is scheduled for Aug 06, 2026.
What are the forecasts for Organogenesis Holdings Inc. Class A Common Stock's next earnings report?
Based on 4
analysts, Organogenesis Holdings Inc. Class A Common Stock is expected to report EPS of -$0.35 and revenue of $55.34M for Q2 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement